TVTY · Tivity Health, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $481.25M | $437.71M | $1.13B | $501.00M | - | - |
| Cost of Revenue | $278.25M | $250.36M | $678.06M | $357.12M | - | - |
| Gross Profit | $203.00M | $187.35M | $453.10M | $143.88M | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $41.99M | $42.99M | $110.04M | $35.11M | $34.36M | $39.48M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $11.30M | $45.89M | $50.77M | $4.67M | $3.36M | $4.08M |
| Operating Income | $143.18M | $117.88M | ($249.84M) | $133.68M | $120.40M | $95.38M |
| Interest Expense | $34.76M | $43.48M | $76.57M | $8.73M | $15.61M | $17.32M |
| Income Tax | $26.34M | $17.53M | ($39.59M) | $27.05M | $43.55M | $21.97M |
| Net Income | $104.91M | ($223.63M) | ($286.82M) | $98.80M | $63.72M | ($129.11M) |
| EPS - Basic | $2.12 | ($4.59) | ($6.17) | $2.47 | $1.62 | ($3.49) |
| EPS - Diluted | $2.08 | ($4.54) | ($6.17) | $2.29 | $1.50 | ($3.39) |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $60.13M | $100.39M | $2.49M | $1.93M | $28.44M | $1.60M |
| Accounts Receivable | $62.73M | $25.98M | $97.60M | $67.14M | $55.11M | $50.42M |
| Inventory | - | - | $274.0K | - | - | - |
| Accounts Payable | $25.32M | $19.74M | $46.48M | $29.10M | $26.80M | $26.03M |
| Current Assets | $195.90M | $154.25M | $161.74M | $78.11M | $223.29M | $58.11M |
| Total Assets | $598.54M | $578.98M | $1.63B | $482.08M | $636.16M | $544.78M |
| Current Liabilities | $87.42M | $81.83M | $146.36M | $81.07M | $358.63M | $132.36M |
| Long-term Debt | $380.50M | $459.25M | $1.05B | $30.59M | $0 | $164.30M |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $118.91M | $3.66M | $226.91M | $369.00M | $271.95M | $189.30M |
| Retained Earnings | ($359.17M) | ($464.08M) | ($237.28M) | $49.66M | ($49.15M) | ($119.33M) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $87.12M | $169.45M | $82.31M | $108.74M | $105.28M | $37.90M |
| Investing Cash Flow | ($15.97M) | $541.04M | ($1.09B) | ($7.64M) | ($5.91M) | ($38.87M) |
| Financing Cash Flow | ($111.40M) | ($612.59M) | $1.01B | ($127.55M) | ($74.31M) | $963.0K |
| CapEx | $14.75M | $15.53M | $24.71M | $9.05M | $5.91M | $14.47M |
| Free Cash Flow | $72.37M | $153.92M | $57.59M | $99.69M | $99.37M | $23.43M |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 42.2% | 42.8% | 40.1% | 28.7% | - | - |
| Operating margin | 29.8% | 26.9% | -22.1% | 26.7% | - | - |
| EBITDA margin | 32.1% | 37.4% | -17.6% | 27.6% | - | - |
| Net margin | 21.8% | -51.1% | -25.4% | 19.7% | - | - |
| Free cash flow margin | 15.0% | 35.2% | 5.1% | 19.9% | - | - |
| FCF / Net income | 0.69 | -0.69 | -0.20 | 1.01 | 1.56 | -0.18 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 8.7% | 9.8% | 9.7% | 7.0% | - | - |
| Effective tax rate | 20.1% | - | - | 21.5% | 40.6% | - |
| Return on assets | 17.5% | -38.6% | -17.6% | 20.5% | 10.0% | -23.7% |
| Return on equity | 88.2% | -6116.8% | -126.4% | 26.8% | 23.4% | -68.2% |
| Return on invested capital | 22.9% | 20.1% | -15.5% | 26.3% | 26.3% | 21.3% |
| Liquidity | ||||||
| Current ratio | 2.24 | 1.88 | 1.11 | 0.96 | 0.62 | 0.44 |
| Quick ratio | 2.24 | 1.88 | 1.10 | 0.96 | 0.62 | 0.44 |
| Cash ratio | 0.69 | 1.23 | 0.02 | 0.02 | 0.08 | 0.01 |
| Leverage | ||||||
| Debt / Equity | 3.20 | 125.62 | 4.62 | 0.08 | 0.00 | 0.87 |
| Debt / Assets | 0.64 | 0.79 | 0.64 | 0.06 | 0.00 | 0.30 |
| Debt / EBITDA | 2.46 | 2.80 | - | 0.22 | 0.00 | 1.65 |
| Interest coverage | 4.1x | 2.7x | -3.3x | 15.3x | 7.7x | 5.5x |
| Equity multiplier | 5.03 | 158.37 | 7.17 | 1.31 | 2.34 | 2.88 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.80 | 0.76 | 0.70 | 1.04 | - | - |
| Inventory turnover | - | - | 2474.66 | - | - | - |
| Days sales outstanding | 48d | 22d | 31d | 49d | - | - |
| Days inventory outstanding | - | - | 0d | - | - | - |
| Days payable outstanding | 33d | 29d | 25d | 30d | - | - |
| Cash conversion cycle | - | - | 7d | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 9.9% | -61.3% | 125.8% | - | - | - |
| Revenue CAGR (3y) | -1.3% | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | 8.4% | -58.7% | 214.9% | - | - | - |
| Operating income growth (YoY) | 21.5% | - | - | 11.0% | 26.2% | 2650.3% |
| Net income growth (YoY) | - | 22.0% | - | 55.1% | - | -317.2% |
| EPS growth (YoY) | - | 26.4% | - | 52.7% | - | -294.2% |
| EPS CAGR (3y) | -3.2% | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | 44.3% | - |
| FCF growth (YoY) | -53.0% | 167.3% | -42.2% | 0.3% | 324.1% | -10.7% |
| FCF CAGR (5y) | 25.3% | 42.5% | 44.6% | 27.0% | - | -18.1% |
| Book value growth (YoY) | 3152.4% | -98.4% | -38.5% | 35.7% | 43.7% | -32.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$481.25M totalSilver Sneakers$362.77M · 75.4%
Prime Fitness$94.25M · 19.6%
Whole Health Living$23.78M · 4.9%
Product And Service Other$454.0K · 0.1%
Stability scores
Piotroski F-score
FY 2021 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Misc Health & Allied Services, NEC
Comparing TIVITY HEALTH against the 5 most active filers in the same SIC group.